This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $22,652.90. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,780.96 and is a firm fixed-price delivery order with a completion date of June 8, 2023. The contract is not designated as a set-aside and was awarded through full and open...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,780.96 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 27, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,122.40, is a Firm Fixed Price Delivery Order with a completion date of June 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $7,030.77 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 10, 2024, with a completion date of January 2, 2025. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,374.36 firm fixed-price contract was awarded on December 18, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of January 10, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the procurement of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML pharmaceuticals. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $61,162.83 with a firm fixed price and an ultimate completion date of August 27, 2024. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The contract, valued at $2,343.59, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price delivery order with a performance period through June 12, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,265.29 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 6, 2024. The contract has an ultimate completion date of September 27, 2024 and does not utilize a set-aside. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA). The $7,030.77 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a completion date of March 19, 2025. The contract is a delivery order under an Indefinite Delivery Contract valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...